He Wu

2.0k total citations
46 papers, 1.6k citations indexed

About

He Wu is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, He Wu has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Neurology and 9 papers in Oncology. Recurrent topics in He Wu's work include Intracerebral and Subarachnoid Hemorrhage Research (18 papers), Kruppel-like factors research (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). He Wu is often cited by papers focused on Intracerebral and Subarachnoid Hemorrhage Research (18 papers), Kruppel-like factors research (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). He Wu collaborates with scholars based in China, United States and Italy. He Wu's co-authors include Jian Wang, Tao Wu, Jiping Qi, Qingwu Yang, Ze Zhang, Hong Lu, Zhen Zhang, Yuejia Song, Xueying Xu and Jessica Wang and has published in prestigious journals such as Blood, Brain Research and Kidney International.

In The Last Decade

He Wu

45 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
He Wu China 20 699 601 430 321 203 46 1.6k
Arantxa Ortega‐Aznar Spain 19 416 0.6× 676 1.1× 505 1.2× 447 1.4× 179 0.9× 27 1.7k
Chuanzhi Duan China 21 661 0.9× 470 0.8× 240 0.6× 204 0.6× 98 0.5× 82 1.4k
Zongduo Guo China 21 514 0.7× 520 0.9× 276 0.6× 172 0.5× 143 0.7× 66 1.3k
Keisuke Ishizawa Japan 21 523 0.7× 495 0.8× 322 0.7× 227 0.7× 74 0.4× 94 1.7k
Enming J. Su United States 19 180 0.3× 491 0.8× 300 0.7× 299 0.9× 163 0.8× 36 1.4k
Toshihisa Sumii United States 11 566 0.8× 788 1.3× 714 1.7× 750 2.3× 124 0.6× 12 2.2k
Xuying He China 18 455 0.7× 388 0.6× 218 0.5× 178 0.6× 100 0.5× 45 1.1k
Weiwei Gao China 19 297 0.4× 791 1.3× 282 0.7× 144 0.4× 201 1.0× 38 1.4k
Gökhan Yılmaz Türkiye 13 217 0.3× 488 0.8× 1.1k 2.5× 384 1.2× 563 2.8× 29 1.9k
Honglu Chao China 20 257 0.4× 785 1.3× 154 0.4× 247 0.8× 122 0.6× 31 1.3k

Countries citing papers authored by He Wu

Since Specialization
Citations

This map shows the geographic impact of He Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Wu more than expected).

Fields of papers citing papers by He Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Wu. The network helps show where He Wu may publish in the future.

Co-authorship network of co-authors of He Wu

This figure shows the co-authorship network connecting the top 25 collaborators of He Wu. A scholar is included among the top collaborators of He Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Wu. He Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yun, Jianqin Li, Jing Zhang, et al.. (2024). PPAB001, a novel bispecific antibody against CD47 and CD24, enhances anti-PD-L1 efficacy in triple-negative breast cancer via reprogramming tumor-associated macrophages towards M1 phenotype. International Immunopharmacology. 144. 113740–113740. 2 indexed citations
2.
Li, Tao, et al.. (2024). Microglial HO-1 aggravates neuronal ferroptosis via regulating iron metabolism and inflammation in the early stage after intracerebral hemorrhage. International Immunopharmacology. 147. 113942–113942. 8 indexed citations
3.
Yang, Yun, He Wu, Bei Zhou, et al.. (2023). Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy. Molecular Therapy — Oncolytics. 31. 100747–100747. 24 indexed citations
4.
Wu, He, Chuanfei Yu, Wanqiu Huang, et al.. (2023). Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305. PubMed. 6(3). 194–210. 1 indexed citations
5.
Wu, He, et al.. (2023). Study for C4-O-Glycosylation of Tetracycline. Tetrahedron Letters. 133. 154829–154829. 1 indexed citations
6.
Wei, Hua, Xuemei Chen, Junmin Wang, et al.. (2020). Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage. 1(2). 99–104. 15 indexed citations
7.
8.
Wu, Yutuan, Qingqing Luo, Xin Li, et al.. (2018). Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population. Journal of Cancer. 9(3). 548–555. 8 indexed citations
9.
Xu, Zhou, Yutuan Wu, Xin Li, et al.. (2017). Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation. Chinese Medical Journal. 130(16). 1995–1996. 1 indexed citations
10.
Zhang, Zhen, Yuejia Song, Ze Zhang, et al.. (2016). Distinct role of heme oxygenase-1 in early- and late-stage intracerebral hemorrhage in 12-month-old mice. Journal of Cerebral Blood Flow & Metabolism. 37(1). 25–38. 77 indexed citations
11.
Zhang, Zhen, Ze Zhang, Hong Lu, et al.. (2016). Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage. Molecular Neurobiology. 54(3). 1874–1886. 221 indexed citations
12.
Ceglia, Ilaria, Amylou C. Dueck, Francesca Masiello, et al.. (2016). Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis. Experimental Hematology. 44(12). 1138–1155.e4. 34 indexed citations
13.
Wei, Hua, He Wu, Min Zhou, et al.. (2015). [Protective effects of recombinant human erythropoietin on oligodendrocyte after cerebral infarction].. PubMed. 44(5). 323–8. 2 indexed citations
14.
Lin-sen, Zan, Yanfeng Xi, He Wu, et al.. (2014). Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia–reperfusion. Neuroscience. 262. 118–128. 64 indexed citations
15.
Wu, He, Jie Jiang, Shiguang Zhao, et al.. (2011). Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: Correlations with angiogenesis and cerebral edema. Neurochemistry International. 58(8). 872–879. 41 indexed citations
16.
Wu, He, Tao Wu, Mingchang Li, & Jian Wang. (2011). Efficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury. Neurobiology of Disease. 45(1). 388–394. 82 indexed citations
17.
Wu, Tao, et al.. (2011). Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain. Journal of Neuroinflammation. 8(1). 22–22. 59 indexed citations
18.
Wu, He, Zhiyi Zhang, Ying Li, et al.. (2010). Time course of upregulation of inflammatory mediators in the hemorrhagic brain in rats: Correlation with brain edema. Neurochemistry International. 57(3). 248–253. 60 indexed citations
19.
Wu, He, Zhiyi Zhang, Xiaoli Hu, et al.. (2010). Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: A postmortem study. Brain Research. 1342. 111–117. 64 indexed citations
20.
Wu, He, et al.. (2008). The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage. Journal of the Neurological Sciences. 270(1-2). 172–183. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arantxa Ortega‐Aznar Breakdown of academic impact, for papers by Chuanzhi Duan Breakdown of academic impact, for papers by Zongduo Guo Breakdown of academic impact, for papers by Keisuke Ishizawa Breakdown of academic impact, for papers by Enming J. Su Breakdown of academic impact, for papers by Toshihisa Sumii Breakdown of academic impact, for papers by Xuying He Breakdown of academic impact, for papers by Weiwei Gao Breakdown of academic impact, for papers by Gökhan Yılmaz Breakdown of academic impact, for papers by Honglu Chao
Rankless by CCL
2026